Right to Health
29 July 2011
World Hepatitis Day: Access to Information on the Quality, Safety and Efficacy of the "Egyptian Interferon" is a right to every HCV Patient in Egypt
The Egyptian Initiative for Personal Rights (EIPR) issued a briefing note on the World Hepatitis Day, 28 July 2011, presenting the most important features of the debate over the quality, safety and efficacy (QSE) of long-lasting interferon, produced by the Egyptian company Minapharm under the trade name 'Reiferon Retard', known by the media as 'Egyptian Interferon'.